Cyclic-GMP-Dependent Protein Kinase Inhibits the Ras/Mitogen-Activated Protein Kinase Pathway

REFERENCES

• Appel, R. G. 1992. Growth-regulatory properties of atrial natriuretic factor. Am. J. Physiol. 262: F911–F918.
   PubMedGoogle Scholar
• Boerth, N. J., N. B. Dey, T. L. Cornwell, and T. M. Lincoln 1997. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J. Vasc. Res. 34: 245–259.
   PubMedGoogle Scholar
• Brondello, J.-M., A. Brunet, J. Pouyssègur, and F. R. McKenzie 1997. The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J. Biol. Chem. 272: 1368–1376.
   PubMed Web of Science ®Google Scholar
• Burgering, B. M., G. J. Pronk, P. C. vanWeeren, P. Chardin, and J. L. Bos 1993. cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J. 12: 4211–4220.
   PubMedGoogle Scholar
• Butt, E., J. Geiger, T. Jarchau, S. M. Lohmann, and U. Walter 1993. The cGMP-dependent protein kinase—gene, protein, and function. Neurochem. Res. 18: 27–42.
   PubMedGoogle Scholar
• Butt, E., C. Nolte, S. Schulz, J. Beltman, J. A. Beavo, B. Jastorff, and U. Walter 1992. Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP. Biochem. Pharmacol. 43: 2591–2600.
   PubMed Web of Science ®Google Scholar
• Chuang, E., D. Barnard, L. Hettich, X.-F. Zhang, J. Avruch, and M. S. Marshall 1994. Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues. Mol. Cell. Biol. 14: 5318–5325.
   PubMedGoogle Scholar
• Cook, S. J., and F. McCormick 1993. Inhibition by cAMP of Ras-dependent activation of Raf. Science 262: 1069–1071.
   PubMed Web of Science ®Google Scholar
• Davis, R. J. 1993. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268: 14553–14556.
   PubMed Web of Science ®Google Scholar
• de Vries-Smits, A. M. M., B. M. T. Burgering, S. J. Leevers, C. J. Marshall, and J. L. Bos 1992. Involvement of p21ras in activation of extracellular signal-regulated kinase 2. Nature 357: 802–805.
   Google Scholar
• Erhardt, P., J. Troppmair, U. R. Rapp, and G. M. Cooper 1995. Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells. Mol. Cell. Biol. 15: 5524–5530.
   PubMedGoogle Scholar
• Garg, U. C., and A. Hassid 1990. Nitric oxide generating vasodilators inhibit mitogenesis and proliferation on BALB/c 3T3 fibroblasts by a cyclic GMP-independent mechanism. Biochem. Biophys. Res. Commun. 171: 474–479.
   PubMedGoogle Scholar
• Graves, L. M., K. E. Bornfeldt, E. W. Raines, B. C. Potts, S. G. Macdonald, R. Ross, and E. G. Krebs 1993. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc. Natl. Acad. Sci. USA 90: 10300–10304.
   PubMed Web of Science ®Google Scholar
• Gudi, T., I. Huvar, M. Meinecke, S. M. Lohmann, G. R. Boss, and R. B. Pilz 1996. Regulation of gene expression by cGMP-dependent protein kinase. J. Biol. Chem. 271: 4597–4600.
   PubMed Web of Science ®Google Scholar
• Gudi, T., S. M. Lohmann, and R. B. Pilz 1997. Regulation of gene expression by cyclic GMP-dependent protein kinase requires nuclear translocation of the kinase: identification of a nuclear localization signal. Mol. Cell. Biol. 17: 5244–5254.
   PubMed Web of Science ®Google Scholar
• Häfner, S., H. S. Adler, H. Mischak, P. Janosch, G. Heidecker, A. Wolfman, S. Fippig, M. Lohse, M. Ueffing, and W. Kolch 1994. Mechanism of inhibition of Raf-1 by protein kinase A. Mol. Cell. Biol. 14: 6696–6703.
   PubMedGoogle Scholar
• Hagiwara, H., A. Inoue, A. Yamaguchi, S. Yokose, M. Furuya, S. Tanaka, and S. Hirose 1996. cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells. Am. J. Physiol. 270: C1311–C1318.
   PubMedGoogle Scholar
• Hallberg, B., S. I. Rayter, and J. Downward 1994. Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation. J. Biol. Chem. 269: 3913–3916.
   PubMedGoogle Scholar
• Hattori, S., D. J. Clanton, T. Satoh, S. Nakamura, Y. Kaziro, M. Kawakita, and T. Y. Shih 1987. Neutralizing monoclonal antibody against ras oncogene product p21 which impairs guanine nucleotide exchange. Mol. Cell. Biol. 7: 1999–2002.
   PubMedGoogle Scholar
• Hordijk, P. L., I. Verlaan, K. Jalink, E. J. vanCorven, and W. H. Moolenaar 1994. cAMP abrogates the p21ras-mitogen-activated protein kinase pathway in fibroblasts. J. Biol. Chem. 269: 3534–3538.
   PubMedGoogle Scholar
• Hutchinson, H. G., P. T. Trindade, D. B. Cunanan, C. F. Wu, and R. E. Pratt 1997. Mechanisms of natriuretic-eptide-induced growth inhibition of vascular smooth muscle cells. Cardiovasc. Res. 35: 158–167.
   PubMed Web of Science ®Google Scholar
• Itoh, H., R. E. Pratt, M. Ohno, and V. J. Dzau 1992. Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells. Hypertension 19: 758–760.
   PubMed Web of Science ®Google Scholar
• Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270: 16483–16486.
   PubMed Web of Science ®Google Scholar
• Keyse, S. M. 1995. An emerging family of dual specificity MAP kinase phosphatases. Biochim. Biophys. Acta 1265: 152–160.
   PubMed Web of Science ®Google Scholar
• Kwak, S. P., D. J. Hakes, K. J. Martell, and J. E. Dixon 1994. Isolation and characterization of a human dual specificity protein-tyrosine phosphatase gene. J. Biol. Chem. 269: 3596–3604.
   PubMed Web of Science ®Google Scholar
• Lange-Carter, C. A., and G. L. Johnson 1994. Ras-dependent growth factor regulation of MEK kinase in PC12 cells. Science 265: 1458–1461.
   PubMed Web of Science ®Google Scholar
• Lohmann, S. M., A. B. Vaandrager, A. Smolenski, U. Walter, and H. R. De Jonge 1997. Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem. Sci. 22: 307–312.
   PubMed Web of Science ®Google Scholar
• Markert, T., A. B. Vaandrager, S. Gambaryan, D. Poehler, C. Haeusler, U. Walter, H. R. De Jonge, T. Jarchau, and S. M. Lohmann 1995. Endogenous expression of type II cGMP-dependent protein kinase mRNA and protein in rat intestine. J. Clin. Investig. 96: 822–830.
   PubMed Web of Science ®Google Scholar
• Marshall, M. 1995. Ras target proteins in eukaryotic cells. FASEB J. 9: 1311–1318.
   PubMed Web of Science ®Google Scholar
• McKenzie, F. R., and J. Pouyssegur 1996. cAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition. cAMP-dependent protein kinase induces a temporal shift in growth factor-stimualted MAP kinases. J. Biol. Chem. 271: 13476–13483.
   PubMed Web of Science ®Google Scholar
• Meinecke, M., J. Geiger, E. Butt, M. Sandberg, T. Jahnsen, T. Chakraborty, U. Walter, T. Jarchau, and S. Lohmann 1994. Human cyclic GMP-dependent protein kinase Iβ overexpression increases phosphorylation of an endogenous focal contact-associated vasodilator-stimulated phosphoprotein without altering the thrombin-evoked calcium response. Mol. Pharmacol. 46: 283–290.
   PubMedGoogle Scholar
• Mischak, H., T. Seitz, P. Janosch, M. Eulitz, H. Steen, M. Schellerer, A. Philipp, and W. Kolch 1996. Negative regulation of Raf-1 by phosphorylation of serine 621. Mol. Cell. Biol. 16: 5409–5418.
   PubMedGoogle Scholar
• Murad, F. 1997. What are the molecular mechanisms for the antiproliferative effects of nitric oxide and cGMP in vascular smooth muscle? Circulation 95: 1101–1103.
   PubMedGoogle Scholar
• Payne, D. M., A. J. Rossomando, P. Martino, A. K. Erickson, J.-H. Her, J. Shabanowitz, D. F. Hunt, M. J. Weber, and T. W. Sturgill 1991. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J. 10: 885–892.
   PubMed Web of Science ®Google Scholar
• Peraldi, P., F. Frödin, J. V. Barnier, V. Calleja, J.-C. Scimeca, C. Filloux, G. Calothy, and E. van Obberghen 1995. Regulation of the MAP kinase cascade in PC12 cells: B-Raf activates MEK-1 (MAP kinase or ERK kinase) and is inhibited by cAMP. FEBS Lett. 357: 290–296.
   PubMed Web of Science ®Google Scholar
• Pöhler, D., E. Butt, J. Meissner, S. Müller, M. Lohse, U. Walter, S. M. Lohmann, and T. Jarchau 1995. Expression, purification and characterization of the cGMP-dependent protein kinase Iβ and II using the baculovirus system. FEBS Lett. 374: 419–425.
   PubMedGoogle Scholar
• Porter, J. G., R. Catalano, G. McEnroe, J. A. Lewicki, and A. A. Protter 1992. C-type natriuretic peptide inhibits growth factor-dependent DNA synthesis in smooth muscle cells. Am. J. Physiol. 263: C1001–C1006.
   PubMed Web of Science ®Google Scholar
• Ruder, T., G. Heidecker, and U. R. Rapp 1992. Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. Genes Dev. 6: 545–556.
   PubMedGoogle Scholar
• Scheele, J. S., R. B. Pilz, L. A. Quilliam, and G. R. Boss 1994. Identification of a Ras-related protein in murine erythroleukemia cells that is a cAMP-dependent protein kinase substrate and is phosphorylated during chemically induced differentiation. J. Biol. Chem. 269: 18599–18606.
   PubMedGoogle Scholar
• Scheele, J. S., J. M. Rhee, and G. R. Boss 1995. Determination of absolute amounts of GDP and GTP bound to Ras in mammalian cells: comparison of parental and Ras-overproducing NIH 3T3 fibroblasts. Proc. Natl. Acad. Sci. USA 92: 1097–1100.
   PubMed Web of Science ®Google Scholar
• Schmidt, H. H. H. W., S. M. Lohmann, and U. Walter 1993. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim. Biophys. Acta 1178: 153–175.
   PubMed Web of Science ®Google Scholar
• Seger, R., and E. Krebs 1995. The MAPK signaling cascade. FASEB J. 9: 726–735.
   PubMed Web of Science ®Google Scholar
• Seth, A., F. A. Gonzalet, S. Gupta, D. L. Raden, and R. J. Davis 1992. Signal transduction within the nucleus by mitogen-activated protein kinase. J. Biol. Chem. 267: 24796–24804.
   PubMedGoogle Scholar
• Sidovar, M. F., Y. He, and L. M. Graves 1997. Phosphorylation of serine 43 is not required for the inhibition of c-Raf-1 kinase by cAMP, abstr. P5A-14 Cellular regulation by protein phosphorylation: forty years of progress. 54University of Washington School of Medicine, Seattle.
   Google Scholar
• Sugimoto, T., M. Haneda, M. Togawa, M. Isono, T. Shikano, S. Araki, T. Nakagawa, A. Kashiwagi, K.-L. Guan, and R. Kikkawa 1996. Atrial natriuretic peptide induces the expression of MKP-1, a mitogen-activated protein kinase phosphatase, in glomerular mesangial cells. J. Biol. Chem. 271: 544–547.
   PubMedGoogle Scholar
• Vaandrager, A. B., and H. R. De Jonge 1996. Signaling by cGMP-dependent protein kinases. Mol. Cell. Biochem. 157: 23–30.
   PubMed Web of Science ®Google Scholar
• Vaillancourt, R. R., A. M. Gardner, and G. L. Johnson 1994. B-Raf-dependent regulation of the MEK-1/mitogen-activated protein kinase pathway in PC12 cells and regulation by cyclic AMP. Mol. Cell. Biol. 14: 6522–6530.
   PubMedGoogle Scholar
• Vojtik, A. B., S. M. Hollenberg, and J. A. Cooper 1993. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74: 204–214.
   Google Scholar
• Vollmar, A. M., K.-N. Schmidt, and R. Schulz 1996. Natriuretic peptide receptors on rat thymocytes: inhibition of proliferation by atrial natriuretic peptide. Endocrinology 137: 1706–1713.
   PubMedGoogle Scholar
• Vossler, M. R., H. Yao, R. D. York, M.-G. Pan, C. S. Rim, and P. J. S. Stork 1997. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Raf1-dependent pathway. Cell 89: 73–82.
   PubMed Web of Science ®Google Scholar
• Whitehurst, C. E., H. Owaki, J. T. Bruder, U. R. Rapp, and T. D. Gepper 1995. The MAP kinase activity of the catalytic domain of RAF-1 is regulated independently of Ras binding in T cells. J. Biol. Chem. 270: 5594–5599.
   PubMedGoogle Scholar
• Wu, J., P. Dent, T. Jelinek, A. Wolfman, M. J. Weber, and T. W. Sturgill 1993. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262: 1065–1068.
   PubMed Web of Science ®Google Scholar
• Yee, W. M., and P. F. Worley 1997. Rheb interacts with Raf-1 kinase and may function to integrate growth factor- and protein kinase A-dependent signals. Mol. Cell. Biol. 17: 921–933.
   PubMed Web of Science ®Google Scholar
• Yu, S.-M., L.-M. Hung, and C.-C. Lin 1997. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. Circulation 5: 1269–1277.
   Google Scholar
• Yu, S. M., Z. J. Cheng, J. H. Guh, F. Y. Lee, and S. C. Kuo 1995. Mechanism of anti-proliferation caused by YC-1, an indazole derivative, in cultured rat A10 vascular smooth-muscle cells. Biochem. J. 306: 787–792.
   PubMed Web of Science ®Google Scholar